Memorial Sloan Kettering Cancer Center (MSK), The Rockefeller University, and Weill Cornell Medicine today announced that the Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI) has renewed its collaborations with partners Takeda Pharmaceutical Company Limited (Takeda) and Bridge Medicines.
Dr. Barbara Hempstead, a preeminent physician-scientist, educator and academic leader, has been appointed dean of the Weill Cornell Graduate School of Medical Sciences, effective Jan. 14.
